Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.27
Delayed Data
As of 3:59pm ET
 -0.02 / -0.61%
Today’s Change
2.65
Today|||52-Week Range
5.70
-18.45%
Year-to-Date

Today’s Trading

Previous close3.29
Today’s open3.29
Day’s range3.26 - 3.30
Volume96,820
Average volume (3 months)150,572
Market cap$139.0M
Dividend yield--
Data as of 3:59pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-14.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
ABEOAbeona Therapeutics ...+0.12+2.88%
EIGREiger BioPharmaceuti...+0.05+0.30%
FBIOFortress Biotech Inc-0.02-0.70%
STMLStemline Therapeutic...+0.29+3.92%
Data as of 3:59pm ET, 08/23/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts

Partner Offers

Search for Jobs